Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sridhar Mani

Showing results (131-140 of 170) with videos related to

Pageof 17
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|April 21, 2019
Pregnane X Receptor Activation Triggers Rapid ATP Release in Primed Macrophages That Mediates NLRP3 Inflammasome ActivationGrace Hudson, Kyle L Flannigan, Vivek Krishna Pulakazhi Venu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2009
A phase I study of eribulin mesylate (E7389), a mechanistically novel inhibitor of microtubule dynamics, in patients with advanced solid malignanciesSanjay Goel, Alain C Mita, Monica Mita, et al.
Cancer Chemotherapy and Pharmacology|August 30, 2011
Phase I dose escalation study of KOS-1584, a novel epothilone, in patients with advanced solid tumorsElaine T Lam, Sanjay Goel, Larry J Schaaf, et al.
Molecular Pharmacology|June 20, 2007
Human pregnane X receptor antagonists and agonists define molecular requirements for different binding sitesSean Ekins, Cheng Chang, Sridhar Mani, et al.
Bioorganic Chemistry|January 21, 2024
In vitro safety signals for potential clinical development of the anti-inflammatory pregnane X receptor agonist FKK6Zdeněk Dvořák, Barbora Vyhlídalová, Petra Pečinková, et al.
Cancer|June 8, 2012
Safety, pharmacokinetics, and activity of EZN-2208, a novel conjugate of polyethylene glycol and SN38, in patients with advanced malignanciesRazelle Kurzrock, Sanjay Goel, Jennifer Wheler, et al.
Molecular Pharmacology|August 9, 2020
Weak Microbial Metabolites: a Treasure Trove for Using Biomimicry to Discover and Optimize DrugsZdenek Dvorak, Max Klapholz, Thomas P Burris, et al.
Nature Structural & Molecular Biology|August 12, 2025
Cytoplasmic PXR regulates glucose metabolism by binding mRNAs and modulating their stabilityXiaofei Wang, Zehua Wang, Sihan Li, et al.
British Journal of Pharmacology|March 21, 2017
Constitutive androstane receptor regulates the intestinal mucosal response to injuryGrace M Hudson, Kyle L Flannigan, Sarah L Erickson, et al.
Seminars in Oncology|October 3, 2003
Pharmacology of oxaliplatin in solid tumor patients with hepatic dysfunction: a preliminary report of the National Cancer Institute Organ Dysfunction Working GroupJames H Doroshow, Timothy W Synold, David Gandara, et al.
Pageof 17

Showing results (131-140 of 170) with videos related to

Sort By:
Pageof 17
The Journal of Pharmacology and Experimental Therapeutics|April 21, 2019
Pregnane X Receptor Activation Triggers Rapid ATP Release in Primed Macrophages That Mediates NLRP3 Inflammasome ActivationGrace Hudson, Kyle L Flannigan, Vivek Krishna Pulakazhi Venu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2009
A phase I study of eribulin mesylate (E7389), a mechanistically novel inhibitor of microtubule dynamics, in patients with advanced solid malignanciesSanjay Goel, Alain C Mita, Monica Mita, et al.
Cancer Chemotherapy and Pharmacology|August 30, 2011
Phase I dose escalation study of KOS-1584, a novel epothilone, in patients with advanced solid tumorsElaine T Lam, Sanjay Goel, Larry J Schaaf, et al.
Molecular Pharmacology|June 20, 2007
Human pregnane X receptor antagonists and agonists define molecular requirements for different binding sitesSean Ekins, Cheng Chang, Sridhar Mani, et al.
Bioorganic Chemistry|January 21, 2024
In vitro safety signals for potential clinical development of the anti-inflammatory pregnane X receptor agonist FKK6Zdeněk Dvořák, Barbora Vyhlídalová, Petra Pečinková, et al.
Cancer|June 8, 2012
Safety, pharmacokinetics, and activity of EZN-2208, a novel conjugate of polyethylene glycol and SN38, in patients with advanced malignanciesRazelle Kurzrock, Sanjay Goel, Jennifer Wheler, et al.
Molecular Pharmacology|August 9, 2020
Weak Microbial Metabolites: a Treasure Trove for Using Biomimicry to Discover and Optimize DrugsZdenek Dvorak, Max Klapholz, Thomas P Burris, et al.
Nature Structural & Molecular Biology|August 12, 2025
Cytoplasmic PXR regulates glucose metabolism by binding mRNAs and modulating their stabilityXiaofei Wang, Zehua Wang, Sihan Li, et al.
British Journal of Pharmacology|March 21, 2017
Constitutive androstane receptor regulates the intestinal mucosal response to injuryGrace M Hudson, Kyle L Flannigan, Sarah L Erickson, et al.
Seminars in Oncology|October 3, 2003
Pharmacology of oxaliplatin in solid tumor patients with hepatic dysfunction: a preliminary report of the National Cancer Institute Organ Dysfunction Working GroupJames H Doroshow, Timothy W Synold, David Gandara, et al.
Pageof 17